211 related articles for article (PubMed ID: 312954)
1. [Clinical application of new synthetic vasopressin 1-deamino-8-D-arginine vasopressin (DDAVP): hemostatic control of von Willebrand's disease (author's transl)].
Kobayashi I; Takahashi H; Sanada M; Takahashi K; Hattori A; Ito M; Sakuragawa N; Shibata A; Shinada S; Tsukada T
Rinsho Ketsueki; 1979 Apr; 20(4):364-71. PubMed ID: 312954
[No Abstract] [Full Text] [Related]
2. [A case of von Willebrand's disease--successful application of 1-deamino-8-D-arginine vasopressin (DDAVP) to ovarian bleeding].
Shiraishi K; Ebata H; Sato K; Tanaka M; Nouno R; Mashiko N; Yamaguchi G; Kubo Y; Tanikawa K; Ide K
Rinsho Ketsueki; 1983 Dec; 24(12):1674-9. PubMed ID: 6608600
[No Abstract] [Full Text] [Related]
3. [Desamino-8-D-arginine vasopressin nose drops in the treatment of mild hemophilia A and von Willebrand's disease].
Streit A; Furlan M; Beck EA
Schweiz Med Wochenschr; 1984 Oct; 114(40):1389-91. PubMed ID: 6333722
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of hemophilia A and von Willebrand's disease with 1-deamino-8-D-arginine vasopressin (DDAVP). Hemophilia and DDAVP].
Ingerslev J; Christiansen SE; Kristensen T; Wallevik K; Bernvil SS
Ugeskr Laeger; 1985 Nov; 147(45):3592-4. PubMed ID: 3907076
[No Abstract] [Full Text] [Related]
5. [Clinical application of 1-deamino-8-D-arginine vasopressin to mild hemophilia A (author's transl)].
Kobayashi I; Takahashi H; Takahashi K; Ito M; Sakuragawa N; Shibata A; Matsuoka M; Shinada S; Tsukada T
Rinsho Ketsueki; 1978 Dec; 19(12):1614-21. PubMed ID: 739615
[No Abstract] [Full Text] [Related]
6. Studies on the pathophysiology and treatment of von Willebrand's disease. V. Properties of factor VIII after DDAVP infusion in variant von Willebrand's disease.
Takahashi H
Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):357-65. PubMed ID: 6791293
[No Abstract] [Full Text] [Related]
7. DDAVP in haemophilia and von Willebrand's disease.
Lancet; 1983 Oct; 2(8353):774-5. PubMed ID: 6137606
[No Abstract] [Full Text] [Related]
8. [A trial of adiuretin-SD use in von Willebrand's disease].
Belykh VI; Belykh SI
Ter Arkh; 1990; 62(7):92-4. PubMed ID: 2123575
[TBL] [Abstract][Full Text] [Related]
9. [Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease].
Fukui H; Takase T
Rinsho Ketsueki; 1985 Jul; 26(7):1069-79. PubMed ID: 3932720
[No Abstract] [Full Text] [Related]
10. Effectiveness of D-arginine vasopressin in von Willebrand's disease.
Bala L; Boggio L; Green D
Curr Hematol Rep; 2005 Jan; 4(1):1-2. PubMed ID: 15610653
[No Abstract] [Full Text] [Related]
11. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes.
Ruggeri ZM; Mannucci PM; Lombardi R; Federici AB; Zimmerman TS
Blood; 1982 Jun; 59(6):1272-8. PubMed ID: 6805532
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with arginine vasopressin (DDAVP) in von Willebrand's disease and mild haemophilia.
Ockelford PA; Menon NC; Berry EW
N Z Med J; 1980 Nov; 92(672):375-8. PubMed ID: 6970907
[TBL] [Abstract][Full Text] [Related]
13. [Response to DDAVP in von Willebrand disease type II C].
Batllé Fonrodona J; López Fernández MF; Martín González R; Fernández Villamor A; López Borrasca A; Lasierra Cirujeda J
Sangre (Barc); 1985; 30(2):181-4. PubMed ID: 3925573
[No Abstract] [Full Text] [Related]
14. DDAVP in von Willebrand's disease: repeated administration and the behaviour of the bleeding time.
Theiss W; Schmidt G
Thromb Res; 1978 Dec; 13(6):1119-23. PubMed ID: 311959
[No Abstract] [Full Text] [Related]
15. No influence of blood group on the responsiveness to desmopressin in type I "platelet normal" von Willebrand's disease.
Castaman G; Rodeghiero F
Thromb Haemost; 1995 Mar; 73(3):551-2. PubMed ID: 7667843
[No Abstract] [Full Text] [Related]
16. [Patients with moderate von Willebrand's disease. Response to Willebrand factor with DDAVP].
Alphonse O
Soins; 1989; (526-527):3-4. PubMed ID: 2814607
[No Abstract] [Full Text] [Related]
17. Desamino-D-arginine vasopressin and bleeding time in von Willebrand's disease.
Isola L; Forster A; Aledort LM
Ann Intern Med; 1984 Nov; 101(5):719-20. PubMed ID: 6435493
[No Abstract] [Full Text] [Related]
18. [DDAVP: alternative therapy in moderate pathology of Factor VIII/von Willebrand].
Vicente V; Alberca I; Moraleda JM; López Borrasca A
Sangre (Barc); 1983; 28(4):531-2. PubMed ID: 6606856
[No Abstract] [Full Text] [Related]
19. 1-Desamino-8-arginine-vasopressin corrects the hemostatic defects in type 2B von Willebrand's disease.
McKeown LP; Connaghan G; Wilson O; Hansmann K; Merryman P; Gralnick HR
Am J Hematol; 1996 Feb; 51(2):158-63. PubMed ID: 8579058
[TBL] [Abstract][Full Text] [Related]
20. 1-Deamino-8-D-arginine-vasopressin--an alternative in the management of mild haemophilia A and von Willebrand's disease.
Niessner H; Korninger C
Wien Klin Wochenschr; 1983 Nov; 95(21):753-7. PubMed ID: 6424339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]